Effects of mineralocorticoid receptor antagonists on new-onset or recurrent atrial fibrillation: a Bayesian and frequentist network meta-analysis of randomized trials.
Event: ESC Congress 2024
Topic: Antiarrhythmic Drug Treatment
Session: Integrated management of atrial fibrillation: addressing comorbidities, risk factors, and lifestyle
